Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FL9UT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,790
Award facts
- Contract value 100% obligated
- $10,790.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10.79K delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 20, 2025, with completion expected by June 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfilled this order under its existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical, a $999.99B prime contract through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs.
RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, making this delivery order consistent with AmerisourceBergen's extensive portfolio of specialty pharmaceutical products supplied to the Defense Health Agency and other federal healthcare systems. The vendor's demonstrated capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains, combined with its significant DLA prime contract vehicle, positions it as a key provider for military pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DB25FL9UT?
SPE2DB25FL9UT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FL9UT worth?
The government has obligated $10,790 on SPE2DB25FL9UT.
Is contract SPE2DB25FL9UT an order under another contract?
Yes. SPE2DB25FL9UT is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB25FL9UT competed?
The extent of competition for SPE2DB25FL9UT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award